Scholarly Index
Daniel Martin Klotz
Boehringer Ingelheim (China); 761 total citations; 34 total publications; best world rank #808
Boehringer Ingelheim (China)
761Total citations
34Total publications
10H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| PARP inhibition in cancer therapy | 2021-2025 | 808 | CN 79 | 80.52 |